D116 Unit 4 Study Guide
Student Name
Western Governors University
D116 Advanced Pharmacology for the Advanced Practice Nurse
Prof. Name
Date
Unit 4 Study Guide
How is Heart Failure Severity Classified According to the NYHA and ACC/AHA Systems?
Heart failure (HF) severity is evaluated using two main classification frameworks: the New York Heart Association (NYHA) functional classification and the American College of Cardiology/American Heart Association (ACC/AHA) staging system. These classifications complement each other by focusing on different aspects of the disease. The NYHA system emphasizes symptoms and the impact of heart failure on physical activity, whereas the ACC/AHA system highlights the structural progression of heart disease, including asymptomatic stages.
NYHA Functional Classification
The NYHA classification categorizes patients based on the degree to which heart failure symptoms limit their physical activity. This system is extensively used in clinical practice to guide treatment decisions and estimate patient prognosis.
NYHA Class | Description |
Class I | No limitation of physical activity; ordinary activity causes no symptoms. |
Class II | Mild limitation; symptoms such as fatigue or shortness of breath occur with ordinary exertion. |
Class III | Marked limitation; symptoms develop with less than ordinary activity. |
Class IV | Unable to carry out any physical activity without discomfort; symptoms may be present even at rest. |
ACC/AHA Heart Failure Staging
The ACC/AHA system describes heart failure as a progressive condition and focuses on prevention and early detection. It categorizes heart failure into four irreversible stages that reflect the development of structural heart disease and symptom manifestation.
ACC/AHA Stage | Description |
Stage A | High risk for heart failure but no structural heart disease or symptoms. |
Stage B | Structural heart disease present but no signs or symptoms of heart failure. |
Stage C | Structural heart disease with current or previous symptoms of heart failure. |
Stage D | Advanced, treatment-resistant heart failure requiring specialized interventions. |
This staging emphasizes early intervention to slow disease progression and improve outcomes (American College of Cardiology/American Heart Association, 2022).
What is the First-Line Treatment for Hypertension?
The initial approach to managing hypertension prioritizes lifestyle modifications aimed at reducing risk factors and potentially delaying or reducing the need for pharmacological treatment. Key lifestyle strategies include:
- Reducing sodium intake in the diet.
- Maintaining a healthy body weight.
- Engaging in regular aerobic physical activity.
- Limiting alcohol consumption.
- Avoiding tobacco use.
- Following heart-healthy dietary patterns such as the DASH diet.
These interventions have been proven to effectively lower blood pressure and improve cardiovascular health overall (Whelton et al., 2018).
How Should Hypertension be Managed in Patients with Asthma?
For patients with both asthma and hypertension, angiotensin-converting enzyme (ACE) inhibitors are typically the preferred antihypertensive drugs. ACE inhibitors, identified by the suffix “-pril,” do not cause bronchoconstriction, unlike nonselective beta-blockers, making them safer in patients with reactive airway diseases. However, side effects like persistent cough may occur, requiring switching to angiotensin receptor blockers (ARBs) if necessary (Brunton, Hilal-Dandan, & Knollmann, 2023).
Why Are ACE Inhibitors Contraindicated During Pregnancy?
ACE inhibitors are contraindicated during pregnancy due to their teratogenic effects, especially in the second and third trimesters. Exposure to these drugs can cause severe fetal complications including:
- Hypotension.
- Abnormal kidney development.
- Reduced amniotic fluid volume.
- Skull and lung malformations.
- Hyperkalemia.
- Possible fetal demise.
Pregnant women on ACE inhibitors should promptly discontinue them and receive alternative therapies under medical supervision (Brunton et al., 2023).
What is the Mechanism of Action, Common Side Effects, and Contraindications of HMG-CoA Reductase Inhibitors?
HMG-CoA reductase inhibitors, commonly called statins, reduce low-density lipoprotein (LDL) cholesterol by blocking the key enzyme in cholesterol synthesis within the liver. This results in increased LDL receptor activity on liver cells, enhancing the removal of LDL cholesterol from the blood.
Common side effects include:
- Headaches.
- Gastrointestinal issues such as indigestion and constipation.
- Skin reactions.
Rare but serious adverse effects include muscle pain, myopathy, and rhabdomyolysis. Statins are contraindicated during pregnancy and lactation due to potential harm to the fetus and infant. Careful monitoring is needed when used with medications affecting cytochrome P450 enzymes (e.g., CYP3A4 inhibitors) to prevent toxicity (Brunton et al., 2023).
Which Patients Should Avoid ACE Inhibitors?
ACE inhibitors should be avoided or used with caution in patients who have:
- Experienced angioedema from previous ACE inhibitor use.
- Are pregnant.
- Have known neutropenia (low white blood cell count).
Additionally, patients with bilateral renal artery stenosis or significant renal impairment require careful monitoring due to the risk of kidney injury when using these drugs (Brunton et al., 2023).
What Are the Main Adverse Effects of Aspirin and Warfarin?
Aspirin and warfarin increase the risk of bleeding complications, including:
- Gastrointestinal bleeding.
- Intracranial hemorrhage.
- Excessive bruising.
The bleeding risk is heightened when these drugs are combined or used in patients with bleeding disorders or uncontrolled hypertension (Gulanick & Myers, 2022).
What Are the Signs of Digoxin Toxicity? What Are Therapeutic and Toxic Serum Levels?
Digoxin has a narrow therapeutic window, with effective serum levels between 0.5 and 0.8 ng/mL. Levels above this range raise the risk of toxicity.
Signs of digoxin toxicity include:
- Gastrointestinal symptoms such as nausea, vomiting, and anorexia.
- Fatigue.
- Visual disturbances like blurred or yellow vision.
- Potentially dangerous cardiac arrhythmias.
Any abnormal heart rhythm in a patient on digoxin requires immediate assessment of serum drug levels (Brunton et al., 2023).
What Precautions Should Be Taken When Prescribing Theophylline? What Medications Interact with Theophylline?
Theophylline is used for long-term management of chronic stable asthma. Patients should be advised never to double a missed dose. Caffeine intake should be limited as it can increase theophylline toxicity by reducing its clearance.
Important drug interactions include:
- Enzyme inducers (e.g., phenobarbital, phenytoin, rifampin), which lower theophylline levels.
- Enzyme inhibitors (e.g., cimetidine, fluoroquinolones like ciprofloxacin), which raise theophylline toxicity risk (National Asthma Education and Prevention Program, 2020).
What is the Relationship Between Thiazide Diuretics and Calcium Excretion?
Thiazide diuretics decrease urinary calcium excretion by promoting calcium reabsorption in the distal convoluted tubule of the nephron. This can lead to a mild increase in serum calcium levels, which may be beneficial for preventing calcium-containing kidney stones but requires monitoring in patients at risk for hypercalcemia (Brunton et al., 2023).
What Are the Side Effects of Mucolytics?
Mucolytics reduce the viscosity of respiratory mucus, facilitating more effective coughing. They are generally well tolerated but can provoke bronchospasm, especially in asthma patients. Therefore, careful observation during use is advised (Gulanick & Myers, 2022).
How Do Sympathomimetics Work?
Sympathomimetics relieve nasal congestion by stimulating alpha-1 adrenergic receptors in the nasal blood vessels. This causes vasoconstriction, reducing blood flow and swelling of the nasal mucosa, thereby improving airflow. However, overuse may lead to rebound nasal congestion (Brunton et al., 2023).
What Are the Side Effects and Drug Interactions of Glucocorticoids? What Specific Assessments Are Needed?
Long-term glucocorticoid use is associated with multiple adverse effects, such as:
- Osteoporosis.
- Increased susceptibility to infections.
- Delayed wound healing.
- Hyperglycemia.
- Muscle weakness.
- Fluid and electrolyte imbalances.
- Growth retardation in children.
- Psychological disturbances (mood swings, psychosis).
- Eye issues (cataracts, glaucoma).
- Peptic ulcers.
- Cushing syndrome.
- Adrenal suppression.
Patients on glucocorticoids should undergo monitoring including bone density, blood glucose levels, electrolytes, eye exams, and infection surveillance. Drug interactions involve potassium-depleting agents, NSAIDs, insulin or oral hypoglycemics, and vaccines, necessitating cautious management (Brunton et al., 2023).
What Is the Stepwise Approach to Asthma Management? Which Medication Classes Are Used in Each Step? How Are Short-Acting and Long-Acting Treatments Differentiated?
Asthma treatment follows a stepwise model based on symptom severity and control. Short-acting beta-agonists (SABAs) provide rapid relief for acute symptoms, while long-acting treatments like inhaled corticosteroids (ICS) and long-acting beta-agonists (LABAs) are used for maintenance.
Additional medications such as leukotriene modifiers, biologics, or systemic corticosteroids are introduced as asthma severity increases (National Asthma Education and Prevention Program, 2020).
Which Antitussives and Decongestants Are Safe During Pregnancy? Which Are Contraindicated?
Medication | Notes |
Diphenhydramine (Benadryl®) | Generally considered safe. |
Dextromethorphan (Robitussin®) | Use cautiously depending on trimester. |
Guaifenesin (Mucinex®) | Considered safe for use. |
Pseudoephedrine | Safe only after the first trimester. |
Saline nasal sprays, nasal strips, Neti pots | Non-pharmacologic options and safe. |
Contraindicated Medications | Reason for Avoidance |
Pseudoephedrine (first trimester) | Potential teratogenic effects. |
Phenylephrine | Risk of fetal harm. |
Benzonatate | Insufficient safety data in pregnancy. |
Dextromethorphan | Use cautiously in early pregnancy. |
Managing symptoms during pregnancy requires balancing maternal relief and fetal safety (Brunton et al., 2023).
References
American College of Cardiology/American Heart Association. (2022). Guideline for the management of heart failure. Journal of the American College of Cardiology, 79(17), e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s: The pharmacological basis of therapeutics (14th ed.). McGraw-Hill Education.
Gulanick, M., & Myers, J. L. (2022). Nursing care plans: Diagnoses, interventions, and outcomes (10th ed.). Elsevier.
National Asthma Education and Prevention Program. (2020). Expert panel report 3: Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute.
Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13–e115.
Get WGU Free MSN Samples
D024
- D024 SEI Skill Sets Discussion – Self-Awareness & Management Insights
- D024 Phase 1 Video Reflection
- D024 CPE Schedule and SEI Reflection Report
- D024 FAQ: Submission and CPE Record Guidance
- D024 Phase 1 Reflection on Leadership and Growth Strategies
- D024 Joy in the Workplace: Force Field Analysis Summary
- D024 Professional Presence & Influence: CPE Record Template Task 1
D025
- D025 Phase 2 Reflection: Insights on Team Leadership and Advocacy
- D025: Phase 1 Reflection on Health Policy Advocacy Insights
- D025 Task 1: Clinical Practice Experience
- D025 Task 1 ISBAR Summary
- D025 Final Exam: Advocacy for Policy Change in Community Health
- D025 Task 2 Advocating for Policy Change to Improve Health Outcomes in the Community
D026
D027
- D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects
- D027 OA Final Exam Study Guide: Key Concepts and Conditions
- D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
- D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
- D027 – Comprehensive Study Guide for Health Disorders and Treatments
- D027 E-Portfolio: Advanced Pathopharmacological Foundations
- D027 Study Guide – Advanced Pathopharmacology Notes
D028
D029
- D029 Narrative Essay: Innovations in Nursing Informatics
- D029 CPE Phase 2
- D029 Emerging Tech Annotated Bibliography for Nursing Care
- D029 Annotated Bibliography
- D029 Population Health Data Paper
- D029 Task 1 E-Portfolio: Clinical Practice Experience Analysis
- D029 Task 1: Analyzing Population Health Data in Strafford Country
D030
D031